{"public_id":"co_a42304cb7536f1d48568aa5cf63a4301","status":"active","merged_into_public_id":null,"resolved_public_id":"co_a42304cb7536f1d48568aa5cf63a4301","name":"clinical outcomes","description":"Patient outcome measures used to evaluate the prognostic value of the model.","aliases":[],"types":["outcome"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"concept","status":"active","confidence":null,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","concept.status"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"papers":[{"corpus_id":252686271,"title":"A novel prognostic model based on three integrin subunit genes-related signature for bladder cancer","citation_count":3,"url":"https://sah.borca.ai/papers/252686271"}],"claims":[{"public_id":"cl_da6fbad8b9bb8af8c4c01adb2486a7b7","text":"The risk model acted as an independent indicator of clinical outcomes in bladder cancer patients.","corpus_id":252686271,"url":"https://sah.borca.ai/claims/cl_da6fbad8b9bb8af8c4c01adb2486a7b7"}],"related_concepts":[],"resolved_url":"https://sah.borca.ai/concepts/co_a42304cb7536f1d48568aa5cf63a4301","url":"https://sah.borca.ai/concepts/co_a42304cb7536f1d48568aa5cf63a4301"}